Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1977 3
1978 3
1979 1
1981 1
1982 3
1983 3
1984 1
1985 1
1986 3
1987 1
1988 3
1991 1
1992 3
1993 3
1994 1
1995 2
1996 2
1998 4
1999 2
2000 1
2002 1
2003 2
2004 1
2005 1
2006 1
2009 2
2013 1
2014 3
2015 2
2016 1
2017 2
2018 1
2020 2
2021 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
IFNα and 5-Aza-2'-deoxycytidine combined with a dendritic-cell targeting DNA vaccine alter tumor immune cell infiltration in the B16F10 melanoma model.
Gordy JT, Sandhu AK, Fessler K, Luo K, Kapoor AR, Ayeh SK, Hui Y, Schill C, Chen F, Wang T, Karanika S, Sunshine JC, Karakousis PC, Markham RB. Gordy JT, et al. Among authors: markham rb. Front Immunol. 2023 Jan 19;13:1074644. doi: 10.3389/fimmu.2022.1074644. eCollection 2022. Front Immunol. 2023. PMID: 36741387 Free PMC article.
A perspective on cellular immunity in the elderly.
Khanna KV, Markham RB. Khanna KV, et al. Among authors: markham rb. Clin Infect Dis. 1999 Apr;28(4):710-3. doi: 10.1086/515206. Clin Infect Dis. 1999. PMID: 10825023 Review.
An intranasal stringent response vaccine targeting dendritic cells as a novel adjunctive therapy against tuberculosis.
Karanika S, Gordy JT, Neupane P, Karantanos T, Ruelas Castillo J, Quijada D, Comstock K, Sandhu AK, Kapoor AR, Hui Y, Ayeh SK, Tasneen R, Krug S, Danchik C, Wang T, Schill C, Markham RB, Karakousis PC. Karanika S, et al. Among authors: markham rb. Front Immunol. 2022 Sep 16;13:972266. doi: 10.3389/fimmu.2022.972266. eCollection 2022. Front Immunol. 2022. PMID: 36189260 Free PMC article.
Combination of a MIP3α-antigen fusion therapeutic DNA vaccine with treatments of IFNα and 5-Aza-2'Deoxycytidine enhances activated effector CD8+ T cells expressing CD11c in the B16F10 melanoma model.
Fessler K, Gordy JT, Sandhu AK, Hui Y, Kapoor AR, Ayeh SK, Karanika S, Karakousis PC, Markham RB. Fessler K, et al. Among authors: markham rb. Res Sq [Preprint]. 2023 Aug 14:rs.3.rs-3243336. doi: 10.21203/rs.3.rs-3243336/v1. Res Sq. 2023. PMID: 37645859 Free PMC article. Preprint.
Seal finger.
Markham RB, Polk BF. Markham RB, et al. Rev Infect Dis. 1979 May-Jun;1(3):567-9. doi: 10.1093/clinids/1.3.567. Rev Infect Dis. 1979. PMID: 575922 No abstract available.
A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses.
Gordy JT, Hui Y, Schill C, Wang T, Chen F, Fessler K, Meza J, Li Y, Taylor AD, Bates RE, Karakousis PC, Pekosz A, Sachithanandham J, Li M, Karanika S, Markham RB. Gordy JT, et al. Among authors: markham rb. Front Immunol. 2024 Feb 2;15:1292059. doi: 10.3389/fimmu.2024.1292059. eCollection 2024. Front Immunol. 2024. PMID: 38370404 Free PMC article.
66 results